SEC Form SC 13G filed by Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
|
(Name of Issuer)
|
Common Stock, par value $0.001 per share
|
(Title of Class of Securities)
|
90400D108
|
(Cusip Number)
|
December 31, 2023
|
(Date of Event which Requires Filing of this Statement)
|
☒
|
Rule 13d-1(b)
|
☐
|
Rule 13d-1(c)
|
☐
|
Rule 13d-1(d)
|
CUSIP No. 90400D108
|
1
|
NAMES OF REPORTING PERSONS
Sands Capital Management, LLC
|
||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See
Instructions)
(a) ☐ (b) ⌧
|
||
3
|
SEC USE ONLY
|
||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
||
NUMBER OF
SHARES BENEFICIALLY
OWNED BY
EACH
REPORTING PERSON WITH
|
5
|
SOLE VOTING POWER
-0-
|
|
6
|
SHARED VOTING POWER
2,955,657
|
||
7
|
SOLE DISPOSITIVE POWER
-0-
|
||
8
|
SHARED DISPOSITIVE POWER
4,118,008
|
||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,118,008
|
||
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (See Instructions)
☐
|
||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.0%
|
||
12
|
TYPE OF REPORTING PERSON (See Instructions)
IA
|
CUSIP No. 90400D108
|
1
|
NAMES OF REPORTING PERSONS
Frank M. Sands
|
||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See
Instructions)
(a) ☐ (b) ⌧
|
||
3
|
SEC USE ONLY
|
||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
|
||
NUMBER OF
SHARES BENEFICIALLY
OWNED BY
EACH
REPORTING PERSON WITH
|
5
|
SOLE VOTING POWER
-0-
|
|
6
|
SHARED VOTING POWER
2,955,657
|
||
7
|
SOLE DISPOSITIVE POWER
-0-
|
||
8
|
SHARED DISPOSITIVE POWER
4,118,008
|
||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,118,008
|
||
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (See Instructions)
☐
|
||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.0%
|
||
12
|
TYPE OF REPORTING PERSON (See Instructions)
IN, HC
|
Item 1. |
Issuer
|
Item 2. |
Identity and Background
|
Item 3. |
If This Statement Is Filed Pursuant to Sections 240.13d-1(b) or 240.13d-2(b) or (c),
Check Whether the Person Filing Is an Entity Specified in (a) - (k):
|
(a) |
[ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
|
(b) |
[ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
|
(c) |
[ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
|
(d) |
[ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8);
|
(e) |
[X] An investment adviser in accordance with Section 240.13d-1(b)(1)(ii)(E);
|
(f) |
[ ] An employee benefit plan or endowment fund in accordance with
|
(g) |
[X] A parent holding company or control person in accordance with Section 240.13d-1(b)(1)(ii)(G);
|
(h) |
[ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
|
(i) |
[ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
|
(j) |
[ ] A non-U.S. institution in accordance with Section 240.13d-1(b)(1)(ii)(J);
|
(k) |
[ ] Group, in accordance with Section 240.13d-1(b)(1)(ii)(K).
|
Item 4. |
Ownership
|
Item 5. |
Ownership of Five Percent or Less of a Class
|
Item 6. |
Ownership of More than Five Percent on Behalf of Another Person
|
Item 7. |
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company
|
Item 8. |
Identification and Classification of Members of the Group
|
Item 9. |
Notice of Dissolution of Group
|
Item 10. |
Certification
|
/s/ Alexandra R. Fulk
|
|
Sands Capital Management, LLC
|
|
By: Alexandra R. Fulk, Chief Compliance Officer, Senior Counsel
|
|
/s/ Frank M. Sands
|
|
Name: Frank M. Sands
|
EXHIBIT 1
|
Joint Acquisition Statement Pursuant to Section 240.13d-1(k)
|
/s/ Alexandra R. Fulk
|
|
Sands Capital Management, LLC
|
|
By: Alexandra R. Fulk, Chief Compliance Officer, Senior Counsel
|
|
/s/ Frank M. Sands
|
|
Name: Frank M. Sands
|